Aberrant promoter methylation contributes to LRIG1 silencing in basal/triple-negative breast cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1532-1827
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Aberrant promoter methylation contributes to LRIG1 silencing in basal/triple-negative breast cancer ; volume:127 ; number:3 ; day:19 ; month:4 ; year:2022 ; pages:436-448 ; date:8.2022
British journal of cancer ; 127, Heft 3 (19.4.2022), 436-448, 8.2022
- Creator
-
Umeh-Garcia, Maxine
O’Geen, Henriette
Simion, Catalina
Gephart, Melanie Hayden
Segal, David J.
Sweeney, Colleen A.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41416-022-01812-8
- URN
-
urn:nbn:de:101:1-2022102311552971618800
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Umeh-Garcia, Maxine
- O’Geen, Henriette
- Simion, Catalina
- Gephart, Melanie Hayden
- Segal, David J.
- Sweeney, Colleen A.
- SpringerLink (Online service)
Other Objects (12)
DNMT inhibitors reverse a specific signature of aberrant promoter DNA methylation and associated gene silencing in AML
Aberrant enhancer hypomethylation contributes to hepatic carcinogenesis through global transcriptional reprogramming
Epigenetic silencing of ZIC4 contributes to cancer progression in hepatocellular carcinoma
Aberrant basal ganglia metabolism in fragile X syndrome: a magnetic resonance spectroscopy study
Aberrant DNA methylation of alternative promoter of DLC1 isoform 1 in meningiomas
MicroRNA-mediated epigenetic silencing of sirtuin1 contributes to impaired angiogenic responses
Silencing HOXD10 by promoter region hypermethylation activates ERK signaling in hepatocellular carcinoma
Alveolar Basal Cells Differentiate towards Secretory Epithelial- and Aberrant Basaloid-like Cells In Vitro
Hypermethylation of EDNRB promoter contributes to the risk of colorectal cancer
Core promoter mutation contributes to abnormal gene expression in bladder cancer
High-risk oral leukoplakia is associated with aberrant promoter methylation of multiple genes
In epithelial cancers, aberrant COL17A1 promoter methylation predicts its misexpression and increased invasion
DNMT inhibitors reverse a specific signature of aberrant promoter DNA methylation and associated gene silencing in AML
Aberrant enhancer hypomethylation contributes to hepatic carcinogenesis through global transcriptional reprogramming
Epigenetic silencing of ZIC4 contributes to cancer progression in hepatocellular carcinoma
Aberrant basal ganglia metabolism in fragile X syndrome: a magnetic resonance spectroscopy study
Aberrant DNA methylation of alternative promoter of DLC1 isoform 1 in meningiomas
MicroRNA-mediated epigenetic silencing of sirtuin1 contributes to impaired angiogenic responses
Silencing HOXD10 by promoter region hypermethylation activates ERK signaling in hepatocellular carcinoma
Alveolar Basal Cells Differentiate towards Secretory Epithelial- and Aberrant Basaloid-like Cells In Vitro
Hypermethylation of EDNRB promoter contributes to the risk of colorectal cancer
Core promoter mutation contributes to abnormal gene expression in bladder cancer
High-risk oral leukoplakia is associated with aberrant promoter methylation of multiple genes
In epithelial cancers, aberrant COL17A1 promoter methylation predicts its misexpression and increased invasion
DNMT inhibitors reverse a specific signature of aberrant promoter DNA methylation and associated gene silencing in AML
Aberrant enhancer hypomethylation contributes to hepatic carcinogenesis through global transcriptional reprogramming
Epigenetic silencing of ZIC4 contributes to cancer progression in hepatocellular carcinoma
Aberrant basal ganglia metabolism in fragile X syndrome: a magnetic resonance spectroscopy study
Aberrant DNA methylation of alternative promoter of DLC1 isoform 1 in meningiomas
MicroRNA-mediated epigenetic silencing of sirtuin1 contributes to impaired angiogenic responses
Silencing HOXD10 by promoter region hypermethylation activates ERK signaling in hepatocellular carcinoma
Alveolar Basal Cells Differentiate towards Secretory Epithelial- and Aberrant Basaloid-like Cells In Vitro
Hypermethylation of EDNRB promoter contributes to the risk of colorectal cancer
Core promoter mutation contributes to abnormal gene expression in bladder cancer
High-risk oral leukoplakia is associated with aberrant promoter methylation of multiple genes